| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
5,582 |
4,592 |
$142K |
| 99213 |
|
4,489 |
3,393 |
$118K |
| 99215 |
Prolong outpt/office vis |
1,041 |
887 |
$44K |
| 96372 |
|
4,273 |
3,084 |
$35K |
| 80305 |
|
4,313 |
3,572 |
$25K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,854 |
1,517 |
$21K |
| 87880 |
|
2,182 |
1,651 |
$9K |
| 87804 |
|
705 |
250 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,651 |
1,933 |
$3K |
| 87811 |
|
178 |
145 |
$2K |
| 87426 |
|
324 |
270 |
$2K |
| 96127 |
|
686 |
305 |
$2K |
| 36415 |
|
2,151 |
1,677 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
311 |
228 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
598 |
479 |
$937.30 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,801 |
1,354 |
$455.20 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
129 |
89 |
$286.79 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
20 |
19 |
$227.26 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
158 |
117 |
$115.72 |
| 81003 |
|
162 |
117 |
$84.86 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
75 |
56 |
$79.93 |
| 90686 |
|
14 |
12 |
$75.15 |
| 92551 |
|
12 |
12 |
$71.17 |
| 90756 |
|
21 |
15 |
$41.98 |
| 3079F |
|
236 |
200 |
$40.17 |
| 81002 |
|
50 |
45 |
$30.37 |
| 3075F |
|
216 |
191 |
$10.19 |
| 3078F |
|
226 |
197 |
$0.34 |
| 3074F |
|
129 |
109 |
$0.22 |
| G0008 |
Administration of influenza virus vaccine |
20 |
13 |
$0.00 |